702 filings
Page 27 of 36
8-K
6zgodfqq1zloo
30 Apr 10
Results of Operations and Financial Condition
12:00am
8-K
ppkl36zf 58m
20 Apr 10
Acorda Therapeutics Announces Investigational New Drug Application Accepted for GGF2 for Treatment of Heart Failure
12:00am
8-K
3dgac vemn
13 Apr 10
Acorda Therapeutics Announces Data on AMPYRAâ„¢ (dalfampridine) Presented at American Academy of Neurology Meeting
12:00am
8-K
dc9wfs50s3e3hfg2
23 Mar 10
Changes in Registrant's Certifying Accountant
12:00am
8-K
00k eaa9yrn5s
22 Mar 10
Other Events
12:00am
8-K
6e6bn3xjm42fru9zroy
1 Mar 10
Other Events
12:00am
8-K
lxa5tha7kp8
23 Feb 10
Acorda Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results
12:00am
8-K
6ovk 2ckiv1
22 Feb 10
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
12:00am
8-K
5vgublqxznm84670bmq9
3 Feb 10
Other Events
12:00am
S-8
kot mnnejpq2
1 Feb 10
Registration of securities for employees
12:00am
8-K
ydoyxhw
29 Jan 10
Departure of Directors or Certain Officers
12:00am
8-K
lmvyg zph1x
25 Jan 10
Acorda Therapeutics Announces FDA Approval of
12:00am
8-K
ywy3op1
25 Jan 10
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
12:00am
8-K
pmpleh b4mj0sj6h
12 Jan 10
Other Events
12:00am
S-3ASR
vk0ak3i bqc
12 Jan 10
Automatic shelf registration
12:00am
CT ORDER
2mhty0a23bgadk
4 Nov 09
Confidential treatment order
12:00am
8-K
6f3h y4vl
3 Nov 09
Results of Operations and Financial Condition
12:00am